PCMA issues statement on the Administration’s Blueprint on drug pricing
Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement today on the Administration’s Blueprint on drug pricing: “We are encouraged that the Administration’s Blueprint raises several proposals that would increase the use o